<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <p content-type="self-citation">
  <mixed-citation publication-type="journal" id="cas14811-cit-1001">
   <string-name>
    <surname>Kobayashi</surname>
    <given-names>N</given-names>
   </string-name>, 
   <string-name>
    <surname>Takeda</surname>
    <given-names>Y</given-names>
   </string-name>, 
   <string-name>
    <surname>Okubo</surname>
    <given-names>N</given-names>
   </string-name>, et al. 
   <article-title>Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma</article-title>. 
   <source xml:lang="en">Cancer Sci</source>. 
   <year>2021</year>;
   <volume>112</volume>:
   <fpage>1936</fpage>â€“
   <lpage>1942</lpage>. 
   <pub-id pub-id-type="doi">10.1111/cas.14811</pub-id>
  </mixed-citation>
 </p>
 <fn-group id="cas14811-ntgp-0001">
  <fn id="cas14811-note-0001">
   <p>Trial registration: Registered 20 April 2013. Registry number: UMIN000010549.</p>
  </fn>
 </fn-group>
</notes>
